PCV51 - COST ANALYSIS OF SAFETY OUTCOMES OF DABIGATRAN VS. WARFARIN IN THE SPANISH NATIONAL HEALTH SERVICE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.598
https://www.valueinhealthjournal.com/article/S1098-3015(18)33898-1/fulltext
Title :
PCV51 - COST ANALYSIS OF SAFETY OUTCOMES OF DABIGATRAN VS. WARFARIN IN THE SPANISH NATIONAL HEALTH SERVICE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33898-1&doi=10.1016/j.jval.2018.09.598
First page :
Section Title :
Open access? :
No
Section Order :
17